Cardiff Oncology, Inc. (CRDF)
0.9073
-0.02
(-2.23%)
USD |
NASDAQ |
Oct 23, 16:00
0.9006
-0.01
(-0.74%)
After-Hours: 20:00
Cardiff Oncology Price to Book Value : 2.342 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.342 |
| October 22, 2026 | 2.396 |
| October 21, 2026 | 2.424 |
| October 20, 2026 | 2.405 |
| October 19, 2026 | 2.287 |
| October 16, 2026 | 2.326 |
| October 15, 2026 | 2.507 |
| October 14, 2026 | 2.513 |
| October 13, 2026 | 2.608 |
| October 12, 2026 | 2.685 |
| October 09, 2026 | 2.788 |
| October 08, 2026 | 2.737 |
| October 07, 2026 | 2.814 |
| October 06, 2026 | 2.763 |
| October 05, 2026 | 2.943 |
| October 02, 2026 | 2.892 |
| October 01, 2026 | 3.047 |
| September 30, 2026 | 3.124 |
| September 29, 2026 | 3.021 |
| September 28, 2026 | 3.098 |
| September 25, 2026 | 3.202 |
| September 24, 2026 | 3.305 |
| September 23, 2026 | 3.382 |
| September 22, 2026 | 3.434 |
| September 21, 2026 | 3.537 |
| Date | Value |
|---|---|
| September 18, 2026 | 3.537 |
| September 17, 2026 | 3.356 |
| September 16, 2026 | 3.486 |
| September 15, 2026 | 3.460 |
| September 14, 2026 | 3.382 |
| September 11, 2026 | 3.124 |
| September 10, 2026 | 3.124 |
| September 09, 2026 | 2.711 |
| September 08, 2026 | 2.84 |
| September 04, 2026 | 2.814 |
| September 03, 2026 | 2.788 |
| September 02, 2026 | 2.737 |
| September 01, 2026 | 2.659 |
| August 31, 2026 | 2.565 |
| August 28, 2026 | 2.427 |
| August 27, 2026 | 2.546 |
| August 26, 2026 | 2.541 |
| August 25, 2026 | 2.634 |
| August 24, 2026 | 2.577 |
| August 21, 2026 | 2.272 |
| August 20, 2026 | 2.346 |
| August 19, 2026 | 2.318 |
| August 18, 2026 | 2.288 |
| August 17, 2026 | 2.335 |
| August 14, 2026 | 2.486 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.034 |
| Vericel Corp. | 5.881 |
Price to Book Value Related Metrics
| PS Ratio | 121.24 |
| Price | 0.9073 |
| Earnings Yield | -65.09% |
| Market Cap | 62.15M |